Overview

Ruxolitinib Treatment in Inclusion Body Myositis

Status:
RECRUITING
Trial end date:
2028-09-10
Target enrollment:
Participant gender:
Summary
Refer to the "Detailed Description" section.
Phase:
PHASE2
Details
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Treatments:
ruxolitinib